The Scientific Intelligence Platform for AI-driven discovery is now available to every organization building on Databricks Boston, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced that Luma, its Scientific Intelligence Platform, has achieved Gold tier status in the Databricks Brickbuilder Partner Network and is now available on the [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ: RGEN, “Repligen”, or the “Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS, “BioLife”), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market. “We [...]

RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC ("Altaris"), an investment firm focused exclusively on the healthcare industry. The transaction was originally announced [...]

VO Health's Molecular Fitness Blood Test™ will utilize deep protein profiling to estimate VO₂ Max and characterize the biological pathways underlying cardiorespiratory fitness and performance MONTREAL -- Nomic Bio Inc., a proteomics company, and VO Health, a company developing blood-based measures of fitness and functional health, today announced that VO Health is using Nomic's proteomics [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ: RGEN, “Repligen”, or the “Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS, “BioLife”), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market. “We [...]

HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and new product roadmaps. The SAB will meet quarterly and consists of five members, Harvard Bioscience President and CEO John Duke and four experienced industry leaders. "The formation of our [...]

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery workflows QIAGEN builds on more than 25 years of biomedical knowledge, with QDI tools used by around 150,000 users VENLO, Netherlands & GERMANTOWN, Md. -- QIAGEN N.V. [...]

Initial results presented at HUPO 2026 World Congress demonstrate how the company’s complementary mass spectrometry and Olink biomarker panels can expand biological associations at population scale to advance disease and therapeutic development research Key Takeaways: Thermo Fisher’s complementary proteomic technologies uncovered more than 2,500 new biological associations: Initial findings from the PRECISE-SG100K study identify 2,762 [...]

Rome, Italy and Needham, MA, USA — Evident announced today that it has completed the acquisition of CrestOptics S.p.A., a Rome-based developer and manufacturer of advanced optical imaging systems for spinning disk confocal and super-resolution microscopy. The acquisition broadens Evident's life science imaging portfolio and deepens its capability in high-speed, high-content 3D imaging for research, [...]

Collaboration combines CellCarta's global clinical trial testing capabilities with Waters' standardized flow cytometry platforms and expertise MONTREAL -- CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framework to jointly pursue companion diagnostic (CDx) and next-generation [...]